Mediprobe Research provides these services:

• General consulting with pharmaceutical companies for Phase II-IV studies in the field of dermatology
• Development of Phase II-IV study protocols, sample size estimation, data management, final reports and manuscripts
• Conduct of Phase II-IV clinical trials in dermatology
• Bioequivalence studies with topical corticosteroids
• Safety and tolerability studies
• Regulatory submissions to Health Canada and to Research Ethics Boards
• Quality of Life Research, Questionnaire Development
• Skin sensitization and irritation studies
• Adherence to Good Clinical Practices (GCP), International Conference on Harmonization
  Guidelines (ICH), and regulatory guidelines in conducting clinical trials in Canada and the U.S.A.
• Independent Research Ethics Board with a short turnaround time
• Publications and presentations at scientific meetings